MedPath

Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse

Phase 1
Completed
Conditions
Gingivitis
Interventions
Drug: Listerine mouthrinse
Drug: Chinese Medicine mouthrinse
Registration Number
NCT01637948
Lead Sponsor
The University of Hong Kong
Brief Summary

Traditional Chinese medicine (TCM) has been seen as the predominant way of treating disease in China over three thousand years. Certain TCM have scientifically proved to have anti-bacterial property. Patients having orthodontic treatment have higher risks of caries and gum diseases. The purpose of this study was to determine whether the use of TCM Mouthrinses in addition to toothbrushing and flossing has an added benefit for orthodontic patients in maintaining proper oral health.

Detailed Description

The aim of this study was to investigate the effects of a Traditional Chinese medicine (TCM) mouthrinse on gingival health and microbial profiles in orthodontic patients. This six-month randomized, single-blinded, parallel controlled clinical trial consists of 90 patients with fixed appliance treatment. The subjects were allocated to (1) negative-control group: oral hygiene instruction (OHI) alone; (2) positive-control group: OHI plus an EO mouthrinse (Listerine®)(3) test group: OHI plus the TCM mouthrinse (5% Fructus mume extract). Clinical examinations included Plaque Index (PI), Bleeding Index (BI) and Modified Gingival Index (MGI). Salivary microbial quantifications included total aerobic and anaerobic bacteria, Streptococci and Lactobacilli counts. Clinical and microbiological examinations were conducted at baseline, 3 and 6 months (T1, T2 and T3).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Subjects who have at less 20 permanent teeth
  • Subjects who have a healthy systemic condition
  • Subjects with age range 13-35.
  • Subjects who are no-smoker;
  • Subjects who haven't taken antibiotic medicine within a 2 week period prior
  • Subjects who do not currently undergo any medication or will undergo any medication in next six months
  • Subjects who have not dental diseases that required ongoing treatment, which would confound the evaluation of result
  • Subjects who are competent in giving consents
  • Subjects who are not pregnant or lactating women
  • Subjects who do not report teeth sensitivity
  • Subjects who are not allergic to ethanol
  • Subjects presented a minimum level of pre-existing gingivitis (MGI>1) but without peridontitis.(probing depth>4mm)
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ListerineListerine mouthrinseessential oil mouthrinse
Chinese medicine mouthrinseChinese Medicine mouthrinse5% Fructus Mume extract and 2% sodium bicarbonate
Primary Outcome Measures
NameTimeMethod
Gingival index6 months

Modified gingival index

Plaque index6 months

plaque index

gingival bleeding index6 months

gingival bleeding index

Secondary Outcome Measures
NameTimeMethod
Salivary cytokines6 months

Salivary inflammatory cytokines (IL-1β and MIF) levels were detected by ELISA assay.

Adverse Events6 months

the number of participants with side effects or adverse events were recorded throughout the whole study time.

Salivary bacteria counts6 months

Salivary microbial quantifications included total aerobic and anaerobic bacteria, streptococci and lactobacilli counts.

Trial Locations

Locations (1)

Faculty of Dentistry, HKU

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath